GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf4
|
ENSMUSG00000003032.8 | Kruppel-like factor 4 (gut) |
Sp3
|
ENSMUSG00000027109.10 | trans-acting transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp3 | mm10_v2_chr2_-_72980402_72980471 | 0.31 | 6.8e-02 | Click! |
Klf4 | mm10_v2_chr4_-_55532453_55532485 | 0.09 | 6.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_17062384 | 20.64 |
ENSMUST00000153833.1
ENSMUST00000108492.2 |
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr7_-_38107490 | 18.08 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr11_+_62077018 | 17.87 |
ENSMUST00000092415.5
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chrX_-_7967817 | 16.22 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr11_+_74619594 | 15.79 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chr15_-_103255433 | 14.52 |
ENSMUST00000075192.6
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr7_-_45211877 | 14.23 |
ENSMUST00000033057.7
|
Dkkl1
|
dickkopf-like 1 |
chr11_-_116581446 | 14.19 |
ENSMUST00000082152.4
|
Ube2o
|
ubiquitin-conjugating enzyme E2O |
chr4_-_43040279 | 14.10 |
ENSMUST00000107958.1
ENSMUST00000107959.1 ENSMUST00000152846.1 |
Fam214b
|
family with sequence similarity 214, member B |
chrX_+_73639414 | 13.96 |
ENSMUST00000019701.8
|
Dusp9
|
dual specificity phosphatase 9 |
chr4_+_155962292 | 13.87 |
ENSMUST00000024338.4
|
Fam132a
|
family with sequence similarity 132, member A |
chr9_+_21029373 | 13.79 |
ENSMUST00000001040.5
|
Icam4
|
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
chr8_-_92355764 | 13.12 |
ENSMUST00000180102.1
ENSMUST00000179421.1 ENSMUST00000179222.1 ENSMUST00000179029.1 |
4933436C20Rik
|
RIKEN cDNA 4933436C20 gene |
chr12_-_4841583 | 12.78 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr2_-_131160006 | 12.78 |
ENSMUST00000103188.3
ENSMUST00000133602.1 ENSMUST00000028800.5 |
1700037H04Rik
|
RIKEN cDNA 1700037H04 gene |
chr4_+_108579445 | 12.75 |
ENSMUST00000102744.3
|
Orc1
|
origin recognition complex, subunit 1 |
chr7_-_4752972 | 12.72 |
ENSMUST00000183971.1
ENSMUST00000182173.1 ENSMUST00000182738.1 ENSMUST00000184143.1 ENSMUST00000182111.1 ENSMUST00000182048.1 ENSMUST00000063324.7 |
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr10_-_81378459 | 11.78 |
ENSMUST00000140901.1
|
Fzr1
|
fizzy/cell division cycle 20 related 1 (Drosophila) |
chr1_-_193035651 | 11.78 |
ENSMUST00000016344.7
|
Syt14
|
synaptotagmin XIV |
chr7_+_16781341 | 11.72 |
ENSMUST00000108496.2
|
Slc1a5
|
solute carrier family 1 (neutral amino acid transporter), member 5 |
chr17_-_56830916 | 11.66 |
ENSMUST00000002444.7
ENSMUST00000086801.5 |
Rfx2
|
regulatory factor X, 2 (influences HLA class II expression) |
chr7_-_17056669 | 11.55 |
ENSMUST00000037762.4
|
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr14_-_79301623 | 11.54 |
ENSMUST00000022595.7
|
Rgcc
|
regulator of cell cycle |
chr4_+_115057410 | 11.26 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr4_-_43046196 | 11.24 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr9_-_21291124 | 10.99 |
ENSMUST00000086374.6
|
Cdkn2d
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr7_+_80294450 | 10.99 |
ENSMUST00000163812.2
ENSMUST00000047558.7 ENSMUST00000174199.1 ENSMUST00000173824.1 ENSMUST00000174172.1 |
Prc1
|
protein regulator of cytokinesis 1 |
chr14_-_70630149 | 10.89 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr7_+_24370255 | 10.66 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr19_-_17356631 | 10.40 |
ENSMUST00000174236.1
|
Gcnt1
|
glucosaminyl (N-acetyl) transferase 1, core 2 |
chr3_-_100489324 | 10.20 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr7_+_79660196 | 10.18 |
ENSMUST00000035977.7
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr7_+_27447978 | 10.17 |
ENSMUST00000037399.9
ENSMUST00000108358.1 |
Blvrb
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr11_+_78301529 | 10.14 |
ENSMUST00000045026.3
|
Spag5
|
sperm associated antigen 5 |
chr6_-_72958097 | 10.06 |
ENSMUST00000114049.1
|
Tmsb10
|
thymosin, beta 10 |
chr8_-_92356103 | 10.04 |
ENSMUST00000034183.3
|
4933436C20Rik
|
RIKEN cDNA 4933436C20 gene |
chr1_-_71103146 | 9.97 |
ENSMUST00000027393.7
|
Bard1
|
BRCA1 associated RING domain 1 |
chr11_-_69948145 | 9.97 |
ENSMUST00000179298.1
ENSMUST00000018710.6 ENSMUST00000135437.1 ENSMUST00000141837.2 ENSMUST00000142500.1 |
Slc2a4
|
solute carrier family 2 (facilitated glucose transporter), member 4 |
chr4_-_133887765 | 9.86 |
ENSMUST00000003741.9
ENSMUST00000105894.4 |
Rps6ka1
|
ribosomal protein S6 kinase polypeptide 1 |
chr12_+_24831583 | 9.85 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr8_+_122282117 | 9.81 |
ENSMUST00000054052.8
|
Zfpm1
|
zinc finger protein, multitype 1 |
chr11_-_96005872 | 9.70 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chr11_-_69605829 | 9.55 |
ENSMUST00000047889.6
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr1_+_136131382 | 9.47 |
ENSMUST00000075164.4
|
Kif21b
|
kinesin family member 21B |
chr8_+_123332676 | 9.44 |
ENSMUST00000010298.6
|
Spire2
|
spire homolog 2 (Drosophila) |
chr8_+_105518736 | 9.42 |
ENSMUST00000034363.5
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr9_-_109849440 | 9.42 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr10_+_79927039 | 9.41 |
ENSMUST00000019708.5
ENSMUST00000105377.1 |
Arid3a
|
AT rich interactive domain 3A (BRIGHT-like) |
chr5_+_137288273 | 9.34 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr5_+_37242025 | 9.31 |
ENSMUST00000114158.2
|
Crmp1
|
collapsin response mediator protein 1 |
chr2_-_180642681 | 9.30 |
ENSMUST00000037877.10
|
Tcfl5
|
transcription factor-like 5 (basic helix-loop-helix) |
chr3_-_127896271 | 9.28 |
ENSMUST00000057198.7
|
5730508B09Rik
|
RIKEN cDNA 5730508B09 gene |
chr10_+_79927330 | 9.17 |
ENSMUST00000105376.1
|
Arid3a
|
AT rich interactive domain 3A (BRIGHT-like) |
chr4_-_117872520 | 9.16 |
ENSMUST00000171052.1
ENSMUST00000166325.1 ENSMUST00000106422.2 |
Ccdc24
|
coiled-coil domain containing 24 |
chr4_-_118620763 | 9.14 |
ENSMUST00000071972.4
|
Wdr65
|
WD repeat domain 65 |
chr7_-_143460989 | 9.09 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr7_-_142657466 | 9.09 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr9_-_44288535 | 9.03 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr4_-_154025657 | 9.02 |
ENSMUST00000146426.1
|
Smim1
|
small integral membrane protein 1 |
chr2_-_26021532 | 8.95 |
ENSMUST00000136750.1
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr10_-_80577285 | 8.85 |
ENSMUST00000038558.8
|
Klf16
|
Kruppel-like factor 16 |
chr4_+_115057683 | 8.85 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr18_+_54422286 | 8.85 |
ENSMUST00000181269.1
|
Redrum
|
Redrum, erythroid developmental long intergenic non-protein coding transcript |
chr10_+_67979709 | 8.81 |
ENSMUST00000117086.1
|
Rtkn2
|
rhotekin 2 |
chr2_+_173021902 | 8.81 |
ENSMUST00000029014.9
|
Rbm38
|
RNA binding motif protein 38 |
chr11_-_55185029 | 8.66 |
ENSMUST00000039305.5
|
Slc36a2
|
solute carrier family 36 (proton/amino acid symporter), member 2 |
chr4_-_154025616 | 8.60 |
ENSMUST00000182191.1
ENSMUST00000146543.2 |
Smim1
|
small integral membrane protein 1 |
chr4_-_117929726 | 8.59 |
ENSMUST00000070816.2
|
Artn
|
artemin |
chr11_-_102365111 | 8.54 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr19_+_7268296 | 8.52 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr10_-_128400448 | 8.51 |
ENSMUST00000167859.1
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr6_+_49367739 | 8.50 |
ENSMUST00000060561.8
ENSMUST00000121903.1 ENSMUST00000134786.1 |
Fam221a
|
family with sequence similarity 221, member A |
chr11_+_11684967 | 8.50 |
ENSMUST00000126058.1
ENSMUST00000141436.1 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr2_-_150668198 | 8.50 |
ENSMUST00000028944.3
|
Acss1
|
acyl-CoA synthetase short-chain family member 1 |
chr17_+_29490812 | 8.49 |
ENSMUST00000024811.6
|
Pim1
|
proviral integration site 1 |
chr4_-_43045686 | 8.40 |
ENSMUST00000107956.1
ENSMUST00000107957.1 |
Fam214b
|
family with sequence similarity 214, member B |
chr2_+_29869484 | 8.39 |
ENSMUST00000047521.6
ENSMUST00000134152.1 |
Cercam
|
cerebral endothelial cell adhesion molecule |
chr8_+_123411424 | 8.39 |
ENSMUST00000071134.3
|
Tubb3
|
tubulin, beta 3 class III |
chr2_-_29869785 | 8.35 |
ENSMUST00000047607.1
|
2600006K01Rik
|
RIKEN cDNA 2600006K01 gene |
chr1_-_167393826 | 8.32 |
ENSMUST00000028005.2
|
Mgst3
|
microsomal glutathione S-transferase 3 |
chr9_+_54698859 | 8.28 |
ENSMUST00000120452.1
|
Dnaja4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr12_-_112829351 | 8.27 |
ENSMUST00000062092.5
|
Cdca4
|
cell division cycle associated 4 |
chrX_-_74246364 | 8.22 |
ENSMUST00000130007.1
|
Flna
|
filamin, alpha |
chr14_+_31208309 | 8.21 |
ENSMUST00000169169.1
|
Tnnc1
|
troponin C, cardiac/slow skeletal |
chr7_-_4812351 | 8.20 |
ENSMUST00000079496.7
|
Ube2s
|
ubiquitin-conjugating enzyme E2S |
chr14_-_60086832 | 8.13 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr2_+_131186942 | 8.09 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr12_+_113156403 | 8.01 |
ENSMUST00000049271.8
|
4930427A07Rik
|
RIKEN cDNA 4930427A07 gene |
chr9_-_123678873 | 8.00 |
ENSMUST00000040960.6
|
Slc6a20a
|
solute carrier family 6 (neurotransmitter transporter), member 20A |
chr6_-_86669136 | 7.98 |
ENSMUST00000001184.7
|
Mxd1
|
MAX dimerization protein 1 |
chr4_-_152477433 | 7.89 |
ENSMUST00000159186.1
ENSMUST00000162017.1 ENSMUST00000030768.2 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr17_+_25717171 | 7.87 |
ENSMUST00000172002.1
|
Gng13
|
guanine nucleotide binding protein (G protein), gamma 13 |
chr7_-_98178254 | 7.83 |
ENSMUST00000040971.7
|
Capn5
|
calpain 5 |
chr10_+_83722865 | 7.78 |
ENSMUST00000150459.1
|
1500009L16Rik
|
RIKEN cDNA 1500009L16 gene |
chr15_-_89425856 | 7.76 |
ENSMUST00000109313.2
|
Cpt1b
|
carnitine palmitoyltransferase 1b, muscle |
chrX_-_136068236 | 7.75 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chr2_-_26021679 | 7.73 |
ENSMUST00000036509.7
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr6_-_72958465 | 7.70 |
ENSMUST00000114050.1
|
Tmsb10
|
thymosin, beta 10 |
chr14_-_69284982 | 7.68 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
Slc25a37
|
solute carrier family 25, member 37 |
chr9_+_111019284 | 7.68 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr18_-_41951187 | 7.68 |
ENSMUST00000070949.4
|
Prelid2
|
PRELI domain containing 2 |
chr19_+_6084983 | 7.64 |
ENSMUST00000025704.2
|
Cdca5
|
cell division cycle associated 5 |
chr11_-_102082464 | 7.63 |
ENSMUST00000100398.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr12_-_109068173 | 7.63 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr7_+_127746775 | 7.62 |
ENSMUST00000033081.7
|
Fbxl19
|
F-box and leucine-rich repeat protein 19 |
chr9_-_65580040 | 7.59 |
ENSMUST00000068944.7
|
Plekho2
|
pleckstrin homology domain containing, family O member 2 |
chr2_-_151009364 | 7.58 |
ENSMUST00000109896.1
|
Ninl
|
ninein-like |
chr7_-_99238564 | 7.58 |
ENSMUST00000064231.7
|
Mogat2
|
monoacylglycerol O-acyltransferase 2 |
chr4_+_120666562 | 7.55 |
ENSMUST00000094814.4
|
Cited4
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
chr15_+_82341179 | 7.54 |
ENSMUST00000050349.2
|
Fam109b
|
family with sequence similarity 109, member B |
chr10_+_80261457 | 7.53 |
ENSMUST00000156935.1
|
Dazap1
|
DAZ associated protein 1 |
chr2_+_153492790 | 7.53 |
ENSMUST00000109783.1
|
4930404H24Rik
|
RIKEN cDNA 4930404H24 gene |
chrX_+_8271133 | 7.51 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chr12_-_69228167 | 7.49 |
ENSMUST00000021359.5
|
Pole2
|
polymerase (DNA directed), epsilon 2 (p59 subunit) |
chr2_-_24935148 | 7.47 |
ENSMUST00000102935.3
ENSMUST00000133934.1 ENSMUST00000028349.7 |
Arrdc1
|
arrestin domain containing 1 |
chr7_+_100493337 | 7.44 |
ENSMUST00000126534.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr5_-_37717122 | 7.40 |
ENSMUST00000094836.4
|
Stk32b
|
serine/threonine kinase 32B |
chr4_+_52439235 | 7.40 |
ENSMUST00000117280.1
ENSMUST00000102915.3 ENSMUST00000142227.1 |
Smc2
|
structural maintenance of chromosomes 2 |
chr8_-_71725696 | 7.36 |
ENSMUST00000153800.1
ENSMUST00000146100.1 |
Fcho1
|
FCH domain only 1 |
chr6_+_39420378 | 7.31 |
ENSMUST00000090237.2
|
Gm10244
|
predicted gene 10244 |
chr8_+_83608175 | 7.30 |
ENSMUST00000005620.8
|
Dnajb1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr4_+_44300876 | 7.29 |
ENSMUST00000045607.5
|
Melk
|
maternal embryonic leucine zipper kinase |
chr8_-_53638945 | 7.27 |
ENSMUST00000047768.4
|
Neil3
|
nei like 3 (E. coli) |
chr11_+_32276893 | 7.26 |
ENSMUST00000145569.1
|
Hba-x
|
hemoglobin X, alpha-like embryonic chain in Hba complex |
chr17_-_79355082 | 7.25 |
ENSMUST00000068958.7
|
Cdc42ep3
|
CDC42 effector protein (Rho GTPase binding) 3 |
chr6_+_30738044 | 7.24 |
ENSMUST00000128398.1
ENSMUST00000163949.2 ENSMUST00000124665.1 |
Mest
|
mesoderm specific transcript |
chr11_-_102946688 | 7.24 |
ENSMUST00000057849.5
|
C1ql1
|
complement component 1, q subcomponent-like 1 |
chr7_-_142656018 | 7.19 |
ENSMUST00000178921.1
|
Igf2
|
insulin-like growth factor 2 |
chr17_-_26201328 | 7.18 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr13_-_55329723 | 7.13 |
ENSMUST00000021941.7
|
Mxd3
|
Max dimerization protein 3 |
chr5_-_113908685 | 7.11 |
ENSMUST00000004646.6
|
Coro1c
|
coronin, actin binding protein 1C |
chr3_+_69004711 | 7.11 |
ENSMUST00000042901.8
|
Smc4
|
structural maintenance of chromosomes 4 |
chr4_-_154026037 | 7.10 |
ENSMUST00000131325.2
ENSMUST00000146054.1 ENSMUST00000126119.1 ENSMUST00000125533.2 |
Smim1
|
small integral membrane protein 1 |
chrX_+_8271642 | 7.09 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr7_+_19282613 | 7.08 |
ENSMUST00000032559.9
|
Rtn2
|
reticulon 2 (Z-band associated protein) |
chr8_-_94876269 | 7.08 |
ENSMUST00000046461.7
|
Dok4
|
docking protein 4 |
chr17_-_26201363 | 7.08 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr9_-_21963568 | 7.07 |
ENSMUST00000006397.5
|
Epor
|
erythropoietin receptor |
chr8_-_123859423 | 7.04 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr5_+_138280516 | 7.03 |
ENSMUST00000048028.8
|
Stag3
|
stromal antigen 3 |
chr5_-_138279960 | 7.02 |
ENSMUST00000014089.7
ENSMUST00000161827.1 |
Gpc2
|
glypican 2 (cerebroglycan) |
chr13_+_73467197 | 6.99 |
ENSMUST00000022099.8
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1 |
chr6_-_39420281 | 6.94 |
ENSMUST00000114822.1
ENSMUST00000051671.4 |
Mkrn1
|
makorin, ring finger protein, 1 |
chr6_-_39419967 | 6.86 |
ENSMUST00000122996.1
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr3_+_108383829 | 6.86 |
ENSMUST00000090561.3
ENSMUST00000102629.1 ENSMUST00000128089.1 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr13_-_107022027 | 6.86 |
ENSMUST00000117539.1
ENSMUST00000122233.1 ENSMUST00000022204.9 ENSMUST00000159772.1 |
Kif2a
|
kinesin family member 2A |
chr19_-_41802028 | 6.85 |
ENSMUST00000026150.8
ENSMUST00000177495.1 ENSMUST00000163265.1 |
Arhgap19
|
Rho GTPase activating protein 19 |
chr1_-_180813534 | 6.83 |
ENSMUST00000159789.1
ENSMUST00000081026.4 |
H3f3a
|
H3 histone, family 3A |
chr18_-_74207771 | 6.82 |
ENSMUST00000040188.8
ENSMUST00000177604.1 |
Ska1
|
spindle and kinetochore associated complex subunit 1 |
chr3_+_69004969 | 6.81 |
ENSMUST00000136502.1
ENSMUST00000107803.1 |
Smc4
|
structural maintenance of chromosomes 4 |
chr5_+_34949435 | 6.79 |
ENSMUST00000030984.7
|
Rgs12
|
regulator of G-protein signaling 12 |
chr17_+_33629408 | 6.77 |
ENSMUST00000165504.1
|
Zfp414
|
zinc finger protein 414 |
chr10_-_62340514 | 6.77 |
ENSMUST00000099691.4
|
Hk1
|
hexokinase 1 |
chr11_+_117849223 | 6.74 |
ENSMUST00000081387.4
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr6_-_7693184 | 6.69 |
ENSMUST00000031766.5
|
Asns
|
asparagine synthetase |
chr19_-_4283033 | 6.68 |
ENSMUST00000167215.1
ENSMUST00000056888.6 |
Ankrd13d
|
ankyrin repeat domain 13 family, member D |
chr6_-_7693110 | 6.66 |
ENSMUST00000126303.1
|
Asns
|
asparagine synthetase |
chr9_-_44288332 | 6.65 |
ENSMUST00000161408.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr6_+_86628174 | 6.64 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr6_-_7692867 | 6.64 |
ENSMUST00000115542.1
ENSMUST00000148349.1 |
Asns
|
asparagine synthetase |
chr15_-_66969616 | 6.58 |
ENSMUST00000170903.1
ENSMUST00000166420.1 ENSMUST00000005256.6 ENSMUST00000164070.1 |
Ndrg1
|
N-myc downstream regulated gene 1 |
chr5_-_115300957 | 6.55 |
ENSMUST00000009157.3
|
Dynll1
|
dynein light chain LC8-type 1 |
chr15_+_89322969 | 6.52 |
ENSMUST00000066991.5
|
Adm2
|
adrenomedullin 2 |
chr17_-_25433775 | 6.48 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr6_-_39420418 | 6.47 |
ENSMUST00000031985.6
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr6_-_83317589 | 6.47 |
ENSMUST00000005810.6
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase |
chr4_+_127169131 | 6.44 |
ENSMUST00000046659.7
|
Dlgap3
|
discs, large (Drosophila) homolog-associated protein 3 |
chr17_+_28801090 | 6.39 |
ENSMUST00000004985.9
|
Brpf3
|
bromodomain and PHD finger containing, 3 |
chr13_+_108316395 | 6.37 |
ENSMUST00000171178.1
|
Depdc1b
|
DEP domain containing 1B |
chr7_+_100495987 | 6.37 |
ENSMUST00000133044.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr2_+_173022360 | 6.36 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chr19_-_4615453 | 6.36 |
ENSMUST00000053597.2
|
Lrfn4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr15_-_64312636 | 6.34 |
ENSMUST00000177083.1
ENSMUST00000177371.1 |
Asap1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
chr4_-_154025867 | 6.34 |
ENSMUST00000130175.1
ENSMUST00000182151.1 |
Smim1
|
small integral membrane protein 1 |
chr15_+_76246747 | 6.31 |
ENSMUST00000023225.6
|
Grina
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
chr3_+_146150174 | 6.30 |
ENSMUST00000098524.4
|
Mcoln2
|
mucolipin 2 |
chr2_+_154791344 | 6.28 |
ENSMUST00000140713.1
ENSMUST00000137333.1 |
Raly
a
|
hnRNP-associated with lethal yellow nonagouti |
chr1_-_180813591 | 6.26 |
ENSMUST00000162118.1
ENSMUST00000159685.1 ENSMUST00000161308.1 |
H3f3a
|
H3 histone, family 3A |
chr11_+_120948480 | 6.25 |
ENSMUST00000070653.6
|
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr2_+_119618717 | 6.23 |
ENSMUST00000028771.7
|
Nusap1
|
nucleolar and spindle associated protein 1 |
chr7_+_13278778 | 6.23 |
ENSMUST00000098814.4
ENSMUST00000146998.1 ENSMUST00000185145.1 |
Lig1
|
ligase I, DNA, ATP-dependent |
chr15_-_103252810 | 6.22 |
ENSMUST00000154510.1
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr17_+_35861318 | 6.22 |
ENSMUST00000074259.8
ENSMUST00000174873.1 |
Nrm
|
nurim (nuclear envelope membrane protein) |
chr10_+_79881023 | 6.21 |
ENSMUST00000166201.1
|
Prtn3
|
proteinase 3 |
chr15_+_78926720 | 6.21 |
ENSMUST00000089377.5
|
Lgals1
|
lectin, galactose binding, soluble 1 |
chr6_-_115762346 | 6.20 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr12_-_81781121 | 6.20 |
ENSMUST00000035987.7
|
Map3k9
|
mitogen-activated protein kinase kinase kinase 9 |
chrX_+_134308084 | 6.19 |
ENSMUST00000081064.5
ENSMUST00000101251.1 ENSMUST00000129782.1 |
Cenpi
|
centromere protein I |
chrX_-_74246534 | 6.19 |
ENSMUST00000101454.2
ENSMUST00000033699.6 |
Flna
|
filamin, alpha |
chr11_-_87875524 | 6.17 |
ENSMUST00000049768.3
|
Epx
|
eosinophil peroxidase |
chr5_+_140505550 | 6.15 |
ENSMUST00000043050.8
ENSMUST00000124142.1 |
Chst12
|
carbohydrate sulfotransferase 12 |
chr19_-_45816007 | 6.15 |
ENSMUST00000079431.3
ENSMUST00000026247.6 ENSMUST00000162528.2 |
Kcnip2
|
Kv channel-interacting protein 2 |
chr8_+_116921735 | 6.14 |
ENSMUST00000034205.4
|
Cenpn
|
centromere protein N |
chr10_-_79874233 | 6.11 |
ENSMUST00000166023.1
ENSMUST00000167707.1 ENSMUST00000165601.1 |
BC005764
|
cDNA sequence BC005764 |
chr17_-_25942821 | 6.11 |
ENSMUST00000148382.1
ENSMUST00000145745.1 |
Pigq
|
phosphatidylinositol glycan anchor biosynthesis, class Q |
chr7_-_4684963 | 6.11 |
ENSMUST00000079970.4
|
Hspbp1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
chr13_+_91461050 | 6.09 |
ENSMUST00000004094.8
ENSMUST00000042122.8 |
Ssbp2
|
single-stranded DNA binding protein 2 |
chrX_+_7842056 | 6.08 |
ENSMUST00000115667.3
ENSMUST00000115668.3 ENSMUST00000115665.1 |
Otud5
|
OTU domain containing 5 |
chr19_-_5273080 | 6.08 |
ENSMUST00000025786.7
|
Pacs1
|
phosphofurin acidic cluster sorting protein 1 |
chr4_+_124700700 | 6.08 |
ENSMUST00000106199.3
ENSMUST00000038684.5 |
Fhl3
|
four and a half LIM domains 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.7 | 26.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
6.5 | 19.4 | GO:0030221 | basophil differentiation(GO:0030221) |
6.1 | 18.2 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
5.6 | 11.3 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
5.5 | 22.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
5.1 | 15.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
5.0 | 20.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
4.9 | 14.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.7 | 14.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
4.0 | 24.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.8 | 11.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.7 | 29.9 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.7 | 29.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
3.7 | 11.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.7 | 14.6 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
3.5 | 17.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
3.5 | 10.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
3.3 | 13.1 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
3.2 | 25.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
3.2 | 12.9 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
3.2 | 12.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.1 | 9.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
3.1 | 9.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.1 | 12.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
3.0 | 12.2 | GO:0015825 | L-serine transport(GO:0015825) |
3.0 | 9.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
3.0 | 15.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.0 | 11.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
2.9 | 8.7 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
2.9 | 2.9 | GO:0039519 | modulation by virus of host autophagy(GO:0039519) |
2.8 | 14.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
2.8 | 22.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.7 | 8.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
2.7 | 10.9 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
2.7 | 5.4 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
2.7 | 8.1 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
2.7 | 13.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.7 | 5.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.6 | 5.3 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
2.6 | 10.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
2.6 | 2.6 | GO:0006971 | hypotonic response(GO:0006971) |
2.6 | 10.3 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
2.5 | 7.5 | GO:0045004 | DNA replication proofreading(GO:0045004) |
2.5 | 12.5 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.5 | 7.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
2.4 | 2.4 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
2.4 | 9.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
2.4 | 7.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
2.4 | 2.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.4 | 11.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.3 | 7.0 | GO:0090169 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
2.3 | 11.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.3 | 20.9 | GO:0002432 | granuloma formation(GO:0002432) |
2.3 | 9.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
2.3 | 11.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
2.3 | 11.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.3 | 4.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
2.2 | 6.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.2 | 17.4 | GO:0007144 | female meiosis I(GO:0007144) |
2.2 | 6.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
2.2 | 6.5 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
2.1 | 23.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.1 | 21.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
2.1 | 36.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.1 | 6.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
2.1 | 14.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.1 | 6.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
2.1 | 24.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
2.1 | 6.2 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
2.1 | 6.2 | GO:0002215 | defense response to nematode(GO:0002215) |
2.0 | 16.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.0 | 6.0 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
2.0 | 6.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.0 | 5.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.9 | 7.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.9 | 5.6 | GO:0036233 | glycine import(GO:0036233) |
1.8 | 11.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.8 | 9.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.8 | 7.2 | GO:0061743 | motor learning(GO:0061743) |
1.8 | 5.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.8 | 10.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.8 | 19.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.8 | 17.7 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.8 | 1.8 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.7 | 10.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
1.7 | 3.4 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
1.7 | 5.2 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.7 | 5.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.7 | 1.7 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
1.7 | 5.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.7 | 5.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.7 | 3.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
1.7 | 6.8 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
1.7 | 13.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.7 | 51.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.7 | 5.0 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
1.6 | 9.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.6 | 8.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.6 | 8.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.6 | 4.9 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.6 | 19.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.6 | 8.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.6 | 3.2 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
1.6 | 8.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
1.6 | 4.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.6 | 4.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
1.6 | 20.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.6 | 11.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.6 | 4.7 | GO:0021623 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
1.6 | 4.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
1.6 | 6.2 | GO:0060032 | notochord regression(GO:0060032) |
1.6 | 15.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.5 | 18.6 | GO:0015816 | glycine transport(GO:0015816) |
1.5 | 12.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.5 | 12.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.5 | 1.5 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
1.5 | 13.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.5 | 6.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.5 | 9.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
1.5 | 5.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.5 | 4.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
1.5 | 13.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.4 | 5.8 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
1.4 | 10.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.4 | 7.1 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.4 | 8.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.4 | 7.0 | GO:0051697 | protein delipidation(GO:0051697) |
1.4 | 4.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.4 | 4.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
1.4 | 1.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
1.4 | 1.4 | GO:0097324 | melanocyte migration(GO:0097324) |
1.4 | 4.1 | GO:0031296 | B cell costimulation(GO:0031296) |
1.4 | 1.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.4 | 4.1 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.4 | 9.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.4 | 8.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.4 | 4.1 | GO:0070295 | renal water absorption(GO:0070295) |
1.4 | 1.4 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
1.3 | 10.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.3 | 1.3 | GO:2001189 | negative regulation of immunological synapse formation(GO:2000521) regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
1.3 | 12.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.3 | 2.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.3 | 4.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
1.3 | 3.9 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
1.3 | 2.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.3 | 7.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.3 | 3.9 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.3 | 2.6 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
1.3 | 5.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.3 | 3.8 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.3 | 30.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.3 | 7.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.3 | 10.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 3.8 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
1.3 | 5.0 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
1.3 | 2.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.3 | 7.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.2 | 5.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.2 | 3.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.2 | 23.6 | GO:0001675 | acrosome assembly(GO:0001675) |
1.2 | 4.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.2 | 11.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
1.2 | 4.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.2 | 7.3 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
1.2 | 3.7 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.2 | 6.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.2 | 9.7 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
1.2 | 3.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.2 | 3.6 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.2 | 2.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.2 | 13.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.2 | 3.6 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
1.2 | 3.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.2 | 4.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.2 | 10.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.2 | 12.8 | GO:0033280 | response to vitamin D(GO:0033280) |
1.2 | 3.5 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.2 | 2.3 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
1.2 | 2.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.2 | 1.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.2 | 3.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.2 | 9.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.2 | 3.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.1 | 5.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.1 | 1.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.1 | 1.1 | GO:0001743 | optic placode formation(GO:0001743) |
1.1 | 6.8 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.1 | 4.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 1.1 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
1.1 | 14.6 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
1.1 | 3.4 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.1 | 1.1 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
1.1 | 3.3 | GO:0050904 | diapedesis(GO:0050904) |
1.1 | 22.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.1 | 4.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.1 | 3.3 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
1.1 | 3.3 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.1 | 2.2 | GO:0015675 | nickel cation transport(GO:0015675) |
1.1 | 3.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.1 | 3.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.1 | 3.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.1 | 2.1 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.1 | 2.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
1.1 | 3.2 | GO:0046144 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
1.1 | 2.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.1 | 3.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.1 | 5.3 | GO:0030421 | defecation(GO:0030421) |
1.0 | 7.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
1.0 | 2.1 | GO:1990523 | bone regeneration(GO:1990523) |
1.0 | 2.1 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
1.0 | 7.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.0 | 3.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
1.0 | 2.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.0 | 13.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.0 | 2.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.0 | 4.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.0 | 8.2 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.0 | 27.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.0 | 3.0 | GO:0061193 | taste bud development(GO:0061193) |
1.0 | 6.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 8.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.0 | 4.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.0 | 4.0 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
1.0 | 4.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.0 | 4.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.0 | 4.0 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.0 | 3.0 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
1.0 | 2.0 | GO:1901355 | response to rapamycin(GO:1901355) |
1.0 | 4.9 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
1.0 | 30.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
1.0 | 3.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.0 | 2.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.0 | 7.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.0 | 5.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.0 | 4.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.0 | 5.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.0 | 3.8 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
0.9 | 2.8 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.9 | 4.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.9 | 3.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 2.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.9 | 4.6 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.9 | 1.8 | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.9 | 0.9 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.9 | 4.6 | GO:0044805 | late nucleophagy(GO:0044805) |
0.9 | 1.8 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.9 | 7.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.9 | 6.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.9 | 6.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.9 | 2.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.9 | 6.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 2.7 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.9 | 13.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.9 | 5.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.9 | 5.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.9 | 7.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.9 | 4.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.9 | 0.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.9 | 4.3 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.9 | 5.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 6.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.9 | 1.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.9 | 14.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.9 | 2.6 | GO:0015811 | L-cystine transport(GO:0015811) |
0.8 | 9.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.8 | 11.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.8 | 0.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.8 | 9.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.8 | 8.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.8 | 2.5 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.8 | 9.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.8 | 3.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 4.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.8 | 14.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 5.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 2.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.8 | 0.8 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.8 | 4.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.8 | 2.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.8 | 1.6 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.8 | 4.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.8 | 9.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.8 | 8.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.8 | 2.4 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.8 | 3.2 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.8 | 3.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.8 | 6.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 0.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.8 | 3.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 3.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.8 | 3.2 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.8 | 1.6 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.8 | 2.4 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.8 | 2.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.8 | 5.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.8 | 7.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.8 | 3.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.8 | 3.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.8 | 1.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.8 | 10.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.8 | 3.1 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.8 | 2.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.8 | 3.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 2.3 | GO:1903632 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.8 | 0.8 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.8 | 1.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.8 | 6.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 3.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.8 | 2.3 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.8 | 3.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.8 | 5.3 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 4.5 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.7 | 1.5 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.7 | 5.9 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 18.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.7 | 32.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.7 | 6.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.7 | 2.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.7 | 0.7 | GO:1901563 | response to camptothecin(GO:1901563) |
0.7 | 1.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.7 | 2.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.7 | 0.7 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.7 | 4.3 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.7 | 2.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 2.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.7 | 2.9 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 3.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.7 | 5.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 3.5 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.7 | 2.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.7 | 2.1 | GO:0051794 | regulation of catagen(GO:0051794) |
0.7 | 2.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.7 | 1.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.7 | 3.5 | GO:0042148 | strand invasion(GO:0042148) |
0.7 | 11.8 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.7 | 2.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 13.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.7 | 1.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.7 | 16.0 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.7 | 2.1 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.7 | 3.4 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 1.4 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.7 | 4.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 1.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 2.7 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 4.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.7 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 2.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.7 | 4.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 4.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.7 | 4.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 1.3 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.7 | 1.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 | 4.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.7 | 6.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 0.7 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.7 | 3.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.7 | 7.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 1.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 3.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 0.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.6 | 1.9 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.6 | 1.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.6 | 1.9 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.6 | 2.5 | GO:0021586 | pons maturation(GO:0021586) |
0.6 | 1.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 2.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.6 | 2.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 20.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.6 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 1.8 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.6 | 4.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 1.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 7.9 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.6 | 6.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 6.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.6 | 5.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.6 | 4.2 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.6 | 0.6 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.6 | 4.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.6 | 2.4 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.6 | 6.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 8.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.6 | 3.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 1.8 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.6 | 1.8 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.6 | 1.2 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.6 | 3.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 5.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 4.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.6 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.6 | 32.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.6 | 1.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 3.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 7.4 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.6 | 4.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.6 | 2.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.6 | 3.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.6 | 1.7 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.6 | 0.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.6 | 1.7 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.6 | 3.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.6 | 1.7 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.6 | 5.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.6 | 1.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.6 | 1.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.6 | 1.7 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 2.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.6 | 1.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.5 | 2.2 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.5 | 4.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 1.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 2.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.5 | 0.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 3.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.5 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.5 | 2.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 2.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 2.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 19.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.5 | 1.1 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.5 | 5.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.5 | 2.6 | GO:0015846 | polyamine transport(GO:0015846) |
0.5 | 2.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 3.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.5 | 1.6 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.5 | 6.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 4.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 7.2 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.5 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.5 | 2.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.5 | 4.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 4.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.5 | 1.5 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.5 | 6.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 2.0 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.5 | 0.5 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.5 | 1.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.5 | 1.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.5 | 3.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.5 | 5.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.5 | 3.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.5 | 1.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 2.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 1.5 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.5 | 0.5 | GO:2000399 | negative regulation of immature T cell proliferation in thymus(GO:0033088) negative regulation of thymocyte aggregation(GO:2000399) |
0.5 | 7.8 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.5 | 1.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.5 | 4.9 | GO:0007099 | centriole replication(GO:0007099) |
0.5 | 4.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.5 | 1.9 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.5 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 1.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 0.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 7.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.5 | 4.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 1.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.5 | 2.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 2.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 1.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 1.4 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 1.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.5 | 2.4 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.5 | 1.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 0.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 3.3 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.5 | 1.4 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 2.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 0.9 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.5 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.5 | 3.7 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 1.8 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.5 | 0.5 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.5 | 2.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 4.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.5 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 0.9 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) |
0.5 | 2.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.5 | 1.4 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.5 | 2.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 6.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 0.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.5 | 1.8 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.4 | 7.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 2.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.4 | 3.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 0.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 1.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 1.8 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 3.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 0.4 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 2.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 1.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.4 | 3.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 1.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.4 | 0.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 2.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.4 | 1.3 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.4 | 0.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 1.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 2.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 6.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.4 | 2.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 1.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 0.9 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.4 | 3.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 8.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 1.3 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.4 | 2.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.4 | 6.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 1.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 2.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.4 | 0.8 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.4 | 4.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 5.0 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.4 | 8.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 0.8 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 1.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.4 | 1.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.4 | 2.9 | GO:0080111 | DNA demethylation(GO:0080111) |
0.4 | 2.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 2.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 0.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 4.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.4 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 5.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 22.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 0.8 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.4 | 1.2 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.4 | 2.8 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 3.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 2.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.4 | 6.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.4 | 1.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.4 | 2.0 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.4 | 2.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 1.2 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) positive regulation of macrophage cytokine production(GO:0060907) |
0.4 | 3.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 5.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 3.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 2.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.4 | 2.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 22.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 3.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.4 | 2.3 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 0.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.4 | 14.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.4 | 8.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.4 | 0.4 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.4 | 1.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.4 | 1.5 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.4 | 4.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 0.7 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
0.4 | 0.4 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.4 | 3.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.4 | 2.6 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.4 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 2.9 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.4 | 3.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 1.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.4 | 3.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.4 | 7.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.4 | 1.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 7.9 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.4 | 2.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.4 | 15.7 | GO:0006414 | translational elongation(GO:0006414) |
0.4 | 1.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 3.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 1.8 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 1.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.1 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.4 | 1.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.4 | 2.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 1.4 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.4 | 1.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.4 | 1.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 14.4 | GO:0042073 | intraciliary transport(GO:0042073) |
0.3 | 1.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 0.7 | GO:0002343 | B cell selection(GO:0002339) peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.3 | 2.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 1.0 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
0.3 | 3.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.3 | 1.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 3.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 3.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 1.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.3 | 1.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 1.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.3 | 3.6 | GO:0072010 | glomerular epithelium development(GO:0072010) |
0.3 | 10.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 1.3 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.3 | 2.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 19.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 1.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 1.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 4.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 3.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 0.3 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 1.6 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 1.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 8.0 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.3 | 1.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 0.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.3 | 1.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 8.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.3 | 9.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 1.6 | GO:0048243 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.3 | 1.3 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.3 | 0.6 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.3 | 0.9 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.3 | 3.8 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 0.9 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.3 | 0.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 0.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 0.3 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.3 | 0.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.3 | 5.3 | GO:0051693 | actin filament capping(GO:0051693) |
0.3 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 0.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 0.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.9 | GO:0007308 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.3 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 1.2 | GO:0010286 | heat acclimation(GO:0010286) |
0.3 | 0.6 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 0.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.3 | 2.1 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.3 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 1.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 3.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.3 | 2.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 9.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.3 | 2.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 2.4 | GO:0099612 | protein localization to axon(GO:0099612) |
0.3 | 6.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 2.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 1.8 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 0.6 | GO:0098792 | xenophagy(GO:0098792) |
0.3 | 2.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 1.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 3.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 3.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.9 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.3 | 4.6 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.3 | 2.9 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.3 | 7.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 2.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 2.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 1.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 2.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 2.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 3.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.3 | 0.8 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 3.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 3.3 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.3 | 1.4 | GO:0070586 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 1.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 0.6 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 2.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 1.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 2.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 1.9 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 13.3 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 1.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 1.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 1.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 0.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 2.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.3 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.3 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 1.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.3 | 4.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 0.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 1.0 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.3 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 3.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 0.5 | GO:0072683 | T cell extravasation(GO:0072683) positive regulation of T cell extravasation(GO:2000409) |
0.3 | 4.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 1.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.0 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.3 | 1.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.3 | 0.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 3.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 2.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 0.3 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.3 | 0.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 6.0 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 1.8 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 2.0 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.2 | 0.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.5 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 1.0 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.2 | 3.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 2.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.2 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.2 | 0.2 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 1.9 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 2.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.2 | 1.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.7 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 1.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.2 | 4.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 2.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 1.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.2 | 0.5 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 4.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 3.9 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 2.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 4.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 4.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 6.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 2.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 2.9 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 7.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 5.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.4 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 0.7 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 2.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 1.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 2.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.7 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.2 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 2.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 3.6 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.2 | 1.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 0.6 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 18.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.6 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 11.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 3.5 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.6 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 1.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 1.4 | GO:0032274 | gonadotropin secretion(GO:0032274) |
0.2 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.8 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 7.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.4 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.2 | 3.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 1.8 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.2 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 1.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 1.8 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.2 | 0.6 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.2 | 2.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.6 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.2 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.2 | 0.6 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 0.4 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.2 | 2.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 10.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 3.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 0.7 | GO:0009651 | response to salt stress(GO:0009651) |
0.2 | 0.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.2 | 10.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 1.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.8 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.2 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 1.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 4.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 2.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 7.9 | GO:0042384 | cilium assembly(GO:0042384) |
0.2 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 7.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 2.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 1.7 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 1.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 1.0 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.2 | 1.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.7 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 1.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 1.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.3 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 1.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 6.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 1.7 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.2 | 0.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.2 | 4.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 7.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 2.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.6 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.2 | 0.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 1.1 | GO:0051611 | serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) |
0.2 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 1.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 1.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.6 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 1.8 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.3 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.1 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) positive regulation of dermatome development(GO:0061184) |
0.1 | 2.0 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.9 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.4 | GO:1901860 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) positive regulation of mitochondrial DNA metabolic process(GO:1901860) stress-induced mitochondrial fusion(GO:1990046) |
0.1 | 1.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.4 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 1.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.8 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 1.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.8 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 1.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 1.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 2.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 15.4 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 3.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.8 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.1 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.3 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 1.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 1.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.4 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 3.7 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.2 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.1 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 3.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 2.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 1.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 4.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 3.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 1.3 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 2.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 2.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.5 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.4 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.3 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.9 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.8 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 3.1 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.1 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.1 | 2.4 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.1 | 0.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 3.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.2 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.1 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.8 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 1.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.9 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 1.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.1 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.1 | 0.2 | GO:0072584 | caveola assembly(GO:0070836) caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 1.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 1.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.4 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 1.0 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.3 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.2 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.0 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.3 | GO:1901910 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 2.8 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 1.3 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 1.7 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 1.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.9 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.7 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.0 | 0.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:2000077 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.0 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.0 | 0.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.4 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.0 | 1.1 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.0 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
0.0 | 0.1 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.2 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.0 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.5 | GO:0015844 | monoamine transport(GO:0015844) |
0.0 | 0.7 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.7 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.0 | 0.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.0 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 0.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.4 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.0 | 0.0 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.7 | 26.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
4.9 | 19.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
4.0 | 20.1 | GO:0031523 | Myb complex(GO:0031523) |
3.8 | 38.2 | GO:0000796 | condensin complex(GO:0000796) |
3.3 | 26.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.0 | 12.1 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
3.0 | 23.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
3.0 | 8.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
2.9 | 11.7 | GO:0014802 | terminal cisterna(GO:0014802) |
2.8 | 11.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
2.8 | 13.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.4 | 9.7 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.4 | 9.7 | GO:0090537 | CERF complex(GO:0090537) |
2.4 | 12.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
2.4 | 21.5 | GO:0008278 | cohesin complex(GO:0008278) |
2.2 | 15.5 | GO:0001740 | Barr body(GO:0001740) |
2.2 | 11.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
2.2 | 6.6 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
2.2 | 2.2 | GO:1902737 | dendritic filopodium(GO:1902737) |
2.1 | 12.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
2.1 | 20.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
2.0 | 9.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.9 | 11.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.9 | 7.5 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
1.8 | 10.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.7 | 10.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
1.7 | 5.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
1.7 | 6.8 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.7 | 18.8 | GO:0001939 | female pronucleus(GO:0001939) |
1.7 | 11.7 | GO:0005638 | lamin filament(GO:0005638) |
1.7 | 10.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.6 | 22.7 | GO:0090543 | Flemming body(GO:0090543) |
1.6 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
1.5 | 7.6 | GO:0000235 | astral microtubule(GO:0000235) |
1.5 | 4.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.5 | 7.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.5 | 16.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.4 | 17.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.4 | 4.3 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.4 | 36.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.4 | 4.2 | GO:0045298 | tubulin complex(GO:0045298) |
1.4 | 4.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.3 | 2.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.3 | 5.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.3 | 7.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.3 | 19.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.3 | 7.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
1.3 | 1.3 | GO:0042585 | germinal vesicle(GO:0042585) |
1.3 | 3.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.3 | 15.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.3 | 6.4 | GO:0044301 | climbing fiber(GO:0044301) |
1.3 | 7.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.3 | 5.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.2 | 7.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.2 | 9.8 | GO:0070652 | HAUS complex(GO:0070652) |
1.2 | 7.2 | GO:0032590 | dendrite membrane(GO:0032590) |
1.2 | 15.6 | GO:0044327 | dendritic spine head(GO:0044327) |
1.2 | 15.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.2 | 2.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.2 | 21.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.2 | 4.6 | GO:0043293 | apoptosome(GO:0043293) |
1.1 | 6.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.1 | 4.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.1 | 3.3 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
1.1 | 11.6 | GO:0005652 | nuclear lamina(GO:0005652) |
1.0 | 6.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.0 | 6.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.0 | 2.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.0 | 2.9 | GO:0000811 | GINS complex(GO:0000811) |
1.0 | 1.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 3.8 | GO:0032021 | NELF complex(GO:0032021) |
0.9 | 14.1 | GO:0042581 | specific granule(GO:0042581) |
0.9 | 6.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.9 | 3.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.9 | 12.9 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 3.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.9 | 3.6 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.9 | 5.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.9 | 1.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 8.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 1.7 | GO:0000805 | X chromosome(GO:0000805) |
0.8 | 14.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.8 | 7.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.8 | 4.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.8 | 41.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.8 | 2.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.8 | 5.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.8 | 0.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.8 | 11.9 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 4.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.8 | 2.4 | GO:0071920 | cleavage body(GO:0071920) |
0.8 | 6.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 2.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 11.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 2.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 3.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.8 | 3.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 7.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.7 | 4.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.7 | 2.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.7 | 7.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 3.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.7 | 5.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 3.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.7 | 2.1 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.7 | 6.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 2.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.7 | 23.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 2.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 3.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 21.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.6 | 9.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.6 | 1.9 | GO:0005940 | septin ring(GO:0005940) |
0.6 | 34.3 | GO:0005657 | replication fork(GO:0005657) |
0.6 | 10.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 1.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 1.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 12.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 4.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 5.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 4.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.6 | 1.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 11.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 8.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 1.7 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.6 | 8.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.6 | 61.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 1.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 9.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.6 | 41.6 | GO:0005844 | polysome(GO:0005844) |
0.6 | 7.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 10.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.6 | 6.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 24.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.5 | 6.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 1.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 3.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 11.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 8.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 7.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 32.2 | GO:0000922 | spindle pole(GO:0000922) |
0.5 | 2.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 3.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 1.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 8.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 36.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.5 | 4.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 8.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 6.1 | GO:0005861 | troponin complex(GO:0005861) |
0.5 | 3.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.5 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 1.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.5 | 1.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.5 | 2.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 1.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.5 | 4.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 33.3 | GO:0000776 | kinetochore(GO:0000776) |
0.5 | 4.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 4.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 14.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.5 | 6.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 3.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 2.3 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.4 | 7.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 0.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 8.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 4.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.4 | 0.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.4 | 2.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 38.6 | GO:0005819 | spindle(GO:0005819) |
0.4 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 2.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 3.0 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 24.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 3.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 0.8 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.4 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 1.2 | GO:0043512 | inhibin A complex(GO:0043512) |
0.4 | 4.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 6.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 4.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 11.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 1.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 3.5 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 2.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 2.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 5.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.4 | 4.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 6.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.4 | 4.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 16.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 1.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 23.9 | GO:0030496 | midbody(GO:0030496) |
0.4 | 16.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.4 | 2.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 2.2 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 6.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 2.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 3.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 2.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 3.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 3.9 | GO:0002102 | podosome(GO:0002102) |
0.4 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 0.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 10.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 4.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 8.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 7.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 2.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 7.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 1.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 7.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 11.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 1.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 0.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.6 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 4.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.3 | 1.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 6.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 1.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 5.0 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 5.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.3 | 2.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.2 | GO:0008623 | CHRAC(GO:0008623) |
0.3 | 12.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 2.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 1.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 8.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 3.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 3.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.3 | 0.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 2.1 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 2.3 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 18.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.3 | 0.8 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.3 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 1.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 14.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 2.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 2.5 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 7.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 1.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 2.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.3 | 2.2 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 1.3 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 1.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.3 | 14.2 | GO:0005814 | centriole(GO:0005814) |
0.3 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 2.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 2.0 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 9.5 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 3.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 3.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 19.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 3.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 10.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 3.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 4.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 3.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 1.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 4.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 1.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 10.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 2.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 3.0 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 5.6 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 3.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.6 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.2 | 5.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.6 | GO:0071007 | U2-type catalytic step 2 spliceosome(GO:0071007) |
0.2 | 3.1 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 13.5 | GO:0016605 | PML body(GO:0016605) |
0.2 | 3.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 2.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.2 | 4.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 6.0 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 5.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 8.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.1 | GO:0034448 | EGO complex(GO:0034448) |
0.2 | 15.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 1.4 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 6.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 3.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 7.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 6.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 1.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 2.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.2 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 14.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.8 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 2.7 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 2.4 | GO:0031082 | BLOC complex(GO:0031082) |
0.2 | 0.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 0.8 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 1.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 7.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 2.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 3.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 2.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.9 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 3.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 3.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 18.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 2.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 17.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 10.7 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 6.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.2 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.1 | 8.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 14.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 15.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 2.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 3.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.3 | GO:0044450 | microtubule organizing center part(GO:0044450) |
0.1 | 0.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 2.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 1.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 4.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 2.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 1.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.0 | 0.5 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 1.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.5 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.1 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 28.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 2.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.0 | GO:1990130 | Iml1 complex(GO:1990130) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.1 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
5.0 | 20.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
4.6 | 18.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
4.2 | 21.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.8 | 22.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
3.7 | 14.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
3.6 | 17.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
3.5 | 10.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
3.3 | 9.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
3.2 | 19.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
3.2 | 19.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
3.1 | 9.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
3.0 | 15.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
3.0 | 11.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.9 | 8.7 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
2.9 | 5.7 | GO:0048030 | disaccharide binding(GO:0048030) |
2.7 | 8.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.6 | 10.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
2.6 | 2.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.6 | 10.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.6 | 7.7 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
2.6 | 7.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.5 | 10.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
2.5 | 10.1 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
2.4 | 7.1 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
2.3 | 2.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.3 | 9.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.2 | 6.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
2.2 | 24.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.2 | 6.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
2.1 | 12.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
2.1 | 16.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.0 | 6.0 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
1.9 | 5.8 | GO:0002113 | interleukin-33 binding(GO:0002113) |
1.9 | 15.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.9 | 5.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.8 | 5.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
1.8 | 7.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.8 | 7.3 | GO:0070052 | collagen V binding(GO:0070052) |
1.8 | 12.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.8 | 5.4 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.8 | 9.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.8 | 8.8 | GO:0043515 | kinetochore binding(GO:0043515) |
1.7 | 5.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.7 | 8.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.7 | 25.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.7 | 26.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.7 | 11.7 | GO:0031013 | troponin I binding(GO:0031013) |
1.7 | 3.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.6 | 4.9 | GO:0004349 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
1.6 | 8.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.6 | 4.9 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
1.5 | 6.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.5 | 9.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
1.5 | 12.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
1.5 | 13.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.5 | 4.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.4 | 10.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.4 | 5.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.4 | 5.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.4 | 4.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.4 | 5.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 6.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.4 | 4.2 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.4 | 2.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.4 | 4.1 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.4 | 16.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.4 | 9.6 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.3 | 4.0 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.3 | 6.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.3 | 5.3 | GO:0030911 | TPR domain binding(GO:0030911) |
1.3 | 1.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.3 | 3.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.2 | 45.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.2 | 11.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.2 | 20.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.2 | 7.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.2 | 4.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
1.2 | 1.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.2 | 6.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.2 | 3.6 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.2 | 4.8 | GO:0070976 | TIR domain binding(GO:0070976) |
1.2 | 3.6 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.2 | 3.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.2 | 5.9 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.2 | 4.7 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.2 | 4.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 6.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.1 | 3.4 | GO:0019002 | GMP binding(GO:0019002) |
1.1 | 3.4 | GO:1902121 | lithocholic acid binding(GO:1902121) D3 vitamins binding(GO:1902271) |
1.1 | 6.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
1.1 | 11.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.1 | 3.4 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
1.1 | 3.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.1 | 8.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.1 | 4.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.1 | 4.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.1 | 8.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 7.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.1 | 8.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.1 | 6.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.1 | 5.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.0 | 35.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 2.1 | GO:0034046 | poly(G) binding(GO:0034046) |
1.0 | 14.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.0 | 3.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.0 | 3.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.0 | 4.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 7.0 | GO:0000150 | recombinase activity(GO:0000150) |
1.0 | 5.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 7.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.0 | 4.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.0 | 4.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.0 | 3.0 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
1.0 | 4.9 | GO:1990188 | euchromatin binding(GO:1990188) |
1.0 | 4.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.0 | 2.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 2.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.0 | 4.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.0 | 25.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.0 | 8.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.9 | 6.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 3.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.9 | 3.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.9 | 2.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.9 | 5.6 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.9 | 10.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.9 | 45.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 21.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 2.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.9 | 7.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.9 | 28.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.9 | 2.6 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.9 | 9.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.9 | 5.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.9 | 4.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 5.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.9 | 2.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.8 | 2.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.8 | 11.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.8 | 6.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.8 | 4.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.8 | 7.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.8 | 2.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.8 | 2.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.8 | 2.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 1.6 | GO:0070401 | NADP+ binding(GO:0070401) |
0.8 | 4.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.8 | 1.6 | GO:0036004 | GAF domain binding(GO:0036004) |
0.8 | 3.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.8 | 3.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.8 | 3.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.8 | 4.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.8 | 3.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.8 | 4.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.8 | 2.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.8 | 3.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.8 | 3.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.8 | 10.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.8 | 1.6 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.8 | 1.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.8 | 3.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 6.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.8 | 3.0 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.8 | 4.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.8 | 1.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 19.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 3.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.7 | 3.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.7 | 1.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.7 | 8.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.7 | 4.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 10.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 2.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.7 | 2.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 8.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.7 | 5.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.7 | 2.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.7 | 8.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 3.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.7 | 2.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.7 | 14.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 9.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 4.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.7 | 5.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.7 | 2.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.7 | 2.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 6.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 2.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 2.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 2.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.7 | 13.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 7.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.7 | 4.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.7 | 2.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.7 | 12.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 5.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 5.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.6 | 7.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 26.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 3.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.6 | 7.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 37.3 | GO:0070888 | E-box binding(GO:0070888) |
0.6 | 3.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 0.6 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.6 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 0.6 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.6 | 4.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 2.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.6 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.6 | 0.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.6 | 3.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.6 | 28.0 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 1.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 3.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 12.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.6 | 12.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 9.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 28.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.6 | 13.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 3.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 0.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.6 | 2.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.6 | 2.3 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.6 | 6.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 1.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.5 | 2.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 10.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.5 | 6.5 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 6.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 2.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 3.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 2.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 7.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 1.6 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.5 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 3.7 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.5 | 2.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 23.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.5 | 2.1 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.5 | 2.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.5 | 1.6 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.5 | 7.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 3.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 15.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.5 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 12.2 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.5 | 3.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 3.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.5 | 1.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 3.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 20.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 10.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 4.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 3.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 1.5 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.5 | 1.0 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.5 | 1.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 2.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.5 | 1.5 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.5 | 1.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.5 | 47.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 20.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 3.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 2.4 | GO:0043532 | angiostatin binding(GO:0043532) |
0.5 | 3.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 4.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.5 | 1.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 3.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 5.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.5 | 2.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 0.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.5 | 5.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 1.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 1.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 2.7 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.5 | 8.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 1.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 16.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 3.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 0.4 | GO:0001132 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.4 | 5.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 1.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 23.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 41.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 2.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 2.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 3.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 1.3 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.4 | 6.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 4.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 3.0 | GO:0019209 | kinase activator activity(GO:0019209) |
0.4 | 11.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 1.7 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.4 | 3.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 13.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.4 | 9.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 5.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.4 | 1.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 4.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 2.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 1.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.4 | 1.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.4 | 6.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.4 | 1.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 4.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 2.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 7.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 2.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.4 | 3.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 3.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 9.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.4 | 1.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 4.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 23.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 1.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.4 | 2.5 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.3 | 1.0 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.3 | 2.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.3 | 9.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 1.0 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.3 | 2.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 1.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.3 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 3.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 9.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 2.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 2.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 3.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 2.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 15.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 1.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 6.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 2.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.3 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 8.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.3 | 4.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 5.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 5.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 10.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 15.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 2.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.3 | 1.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.3 | 1.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.3 | 2.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 51.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.3 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 8.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 9.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.9 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.3 | 0.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.3 | 4.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 45.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 3.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 18.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 2.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 0.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 2.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 6.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 8.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 1.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 2.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 1.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 8.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 3.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 4.6 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 1.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 2.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 2.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.3 | 2.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 1.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 0.8 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.3 | 2.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 5.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 4.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 2.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.5 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.2 | 1.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 1.4 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 6.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.9 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.2 | 2.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 0.7 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.2 | 1.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 0.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 1.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 5.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 5.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 3.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 0.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 4.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 11.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 1.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 3.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 6.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 4.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 6.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.8 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 1.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 3.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 1.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 0.8 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.2 | 8.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 1.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 32.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 1.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 3.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 11.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 2.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 1.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 3.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.0 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.7 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.2 | 1.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.7 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 3.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 3.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 0.9 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 2.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 3.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.2 | 24.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.8 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 7.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 25.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.2 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.2 | 4.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.5 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.2 | 2.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 1.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.5 | GO:0004335 | galactokinase activity(GO:0004335) |
0.2 | 0.6 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.2 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.1 | 1.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 4.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 53.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.7 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 4.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 2.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 2.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 1.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 35.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 3.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 3.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 5.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 3.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.9 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.7 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 1.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 2.9 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 2.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 2.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.9 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 8.6 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 2.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.4 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) |
0.1 | 0.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 10.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.1 | 7.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.9 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 2.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 4.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 1.0 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 9.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 6.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 1.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 8.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 3.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 1.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 4.1 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 1.8 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.3 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 1.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 4.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.1 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0003681 | bent DNA binding(GO:0003681) |
0.0 | 2.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 1.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.0 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.0 | 3.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 44.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.7 | 109.6 | PID PLK1 PATHWAY | PLK1 signaling events |
1.6 | 36.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.4 | 60.2 | PID AURORA B PATHWAY | Aurora B signaling |
1.3 | 2.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.1 | 3.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.9 | 1.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.9 | 9.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.8 | 14.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 42.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.7 | 3.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.7 | 1.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.7 | 25.3 | PID ATR PATHWAY | ATR signaling pathway |
0.7 | 26.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 25.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 63.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 30.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 6.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 52.0 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 13.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 4.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.6 | 8.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 24.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 26.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 52.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 20.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 4.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 4.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 11.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 14.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 19.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.5 | 2.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 6.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 3.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 13.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 4.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 6.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 2.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 15.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 1.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 20.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 13.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 8.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 7.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 9.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.4 | 3.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 16.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 3.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 4.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 6.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 20.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 6.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 5.9 | PID ATM PATHWAY | ATM pathway |
0.3 | 1.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 3.7 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 2.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 3.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 2.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 6.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 13.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 24.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 22.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 17.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 13.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 1.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 3.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 6.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 12.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 3.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 1.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 11.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 1.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 5.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 10.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 4.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 19.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 6.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 6.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 3.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 5.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 14.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 58.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
2.1 | 16.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
2.0 | 27.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.6 | 11.4 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.6 | 1.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
1.5 | 39.3 | REACTOME KINESINS | Genes involved in Kinesins |
1.4 | 43.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.4 | 7.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.4 | 28.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.3 | 17.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.3 | 28.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 18.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.2 | 7.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.2 | 29.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.2 | 18.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.1 | 111.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 20.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 21.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 35.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.1 | 6.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.0 | 2.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.0 | 10.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.0 | 10.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.0 | 5.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.0 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 25.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.9 | 13.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.9 | 11.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.9 | 3.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 21.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.9 | 27.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 20.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 36.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.8 | 30.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 10.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 5.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 17.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.7 | 7.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 11.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.7 | 5.4 | REACTOME OPSINS | Genes involved in Opsins |
0.7 | 11.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 15.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.7 | 69.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 25.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 9.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 10.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.6 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 27.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 12.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 12.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 6.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 65.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 1.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 7.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 6.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 31.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 2.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.5 | 28.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 46.4 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.5 | 6.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.5 | 9.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 7.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 1.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.5 | 10.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 19.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.5 | 1.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 9.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 9.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.5 | 4.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.5 | 0.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 8.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 1.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 17.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 13.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 22.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 2.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 16.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 6.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 5.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 7.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 8.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 7.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 5.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 9.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 2.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 15.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 17.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 22.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 3.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 10.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 1.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 7.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.4 | 4.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 1.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 2.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 7.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 4.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 4.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 6.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 7.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 14.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 7.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 8.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 0.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 3.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 1.4 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.3 | 3.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 4.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 4.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 5.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.3 | 9.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 7.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 2.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 6.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 19.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 47.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 10.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 5.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 3.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 6.9 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.2 | 4.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 14.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 3.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 4.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.2 | 0.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 1.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.6 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 5.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 4.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 3.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 1.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 2.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 3.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 10.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 16.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 11.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 6.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 18.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.6 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |